BiotechTube

Interferon-beta-1a + methylprednisolone

ApprovedCompleted
0 watching 0 views this week🔥 Hot
82
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
✓
Phase 2
✓
Phase 3
5
Approved
Indication / Disease

Relapsing-Remitting Multiple Sclerosis

Conditions

Relapsing-Remitting Multiple Sclerosis

Trial Timeline

Mar 1, 2003 → Aug 1, 2006

NCT ID
NCT00492466

About Interferon-beta-1a + methylprednisolone

Interferon-beta-1a + methylprednisolone is a approved stage product being developed by Biogen for Relapsing-Remitting Multiple Sclerosis. The current trial status is completed. This product is registered under clinical trial identifier NCT00492466. Target conditions include Relapsing-Remitting Multiple Sclerosis.

Hype Score Breakdown

Clinical
30
Activity
20
Company
7
Novelty
10
Community
12

Clinical Trials (2)

NCT IDPhaseStatus
NCT00493116ApprovedCompleted
NCT00492466ApprovedCompleted

Competing Products

20 competing products in Relapsing-Remitting Multiple Sclerosis

See all competitors
ProductCompanyStageHype Score
CT-P53 + US-Ocrevus + EU-OcrevusCelltrionPhase 3
77
LY2127399 + PlaceboEli LillyPhase 2
52
BIIB019 (Daclizumab High Yield Process) + PlaceboAbbViePhase 2
52
DaclizumabAbbViePhase 3
77
BIIB019 (Daclizumab High Yield Process) + PlaceboAbbViePhase 2
52
BIIB019 (Daclizumab) + trivalent seasonal influenza vaccineAbbViePhase 2
52
BIIB019 (Daclizumab)AbbViePhase 3
77
BIIB019 (Daclizumab High Yield Process) + Interferon beta-1a Placebo + Interferon beta-1a + Daclizumab High Yield Process PlaceboAbbViePhase 3
77
Rebif (Interferon beta-1a)MerckPre-clinical
23
Interferon beta-1aMerckPre-clinical
23
Rebif® + Avonex®MerckPhase 3
77
Rebif® + Rebif®MerckApproved
85
VigantOL oil plus interferon beta-1a (Rebif) + Placebo plus interferon beta-1a (Rebif) + Interferon beta-1a (Rebif®) aloneMerckPhase 2
52
Placebo + IFN beta-1a + MethylprednisoloneMerckPhase 2
52
Interferon beta-1a (Rebif)MerckApproved
85
Evobrutinib + Avonex® + Avonex® matched Placebo + Evobrutinib matched PlaceboMerckPhase 3
77
Evobrutinib + Avonex® + Avonex® matched Placebo + Evobrutinib matched PlaceboMerckPhase 3
77
Interferon beta 1aMerckPre-clinical
23
Cladribine 10 mg oral tabletMerckApproved
85
Evobrutinib + Evobrutinib + Evobrutinib + Placebo + TecfideraMerckPhase 2
52

Other Products from Biogen

Dimethyl fumarateApproved
82
[18F]Florbetapir PET imagingApproved
82
dimethyl fumarateApproved
82
ibritumomab tiuxetan (Zevalin®)Approved
82
Dimethyl FumarateApproved
82